Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human, Phase I/II PET Imaging Study of 64Cu-GRIP B, a Radiotracer Targeting Granzyme B, in Patients With Advanced Malignancies

NCT05888532 is registered in ClinicalTrials.gov with Rahul Aggarwal as lead sponsor.

NCT NCT05888532
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05888532 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human, Phase I/II PET Imaging Study of 64Cu-GRIP B, a Radiotracer Targeting Granzyme B, in Patients With Advanced Malignancies
Lead sponsor
Rahul Aggarwal
Phase
Phase 1/2
Overall status
Recruiting
Start date
May 25, 2023
Completion date
January 31, 2027
Enrollment
91 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumor, metastatic castration-resistant prostate cancer, prostate cancer, renal cancer, solid tumor, adult, urethral cancer